Advisor Group Holdings, Inc. Ligand Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 100,742 shares of LGND stock, worth $20.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

100,742

Previous 5,860 1619.15%

Holding current value

$20.2 Million

Previous $666,000 2579.43%

% of portfolio

0.03%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$112.56 - $177.14 $10.7 Million - $16.8 Million	94,882 Added 1619.15%	100,742 $17.8 Million
Q2 2025 Sep 04, 2025	BUY	$96.67 - $118.22 $132,824 - $162,434	1,374 Added 30.63%	5,860 $666,000
Q2 2025 Aug 13, 2025	BUY	$96.67 - $118.22 $224,371 - $274,388	2,321 Added 107.21%	4,486 $509,000
Q1 2025 May 12, 2025	SELL	$105.14 - $122.23 $41,109 - $47,791	-391 Reduced 15.3%	2,165 $227,000
Q4 2024 Jun 06, 2025	SELL	$99.95 - $129.9 $12,493 - $16,237	-125 Reduced 5.77%	2,040 $218,000

Q4 2024 Feb 07, 2025	SELL	$99.95 - $129.9 $126,936 - $164,973	-1,270 Reduced 33.19%	2,556 $273,000
Q3 2024 Nov 13, 2024	BUY	$82.7 - $110.11 $38,620 - $51,421	467 Added 13.9%	3,826 $383,000
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $186,538 - $239,291	2,722 Added 427.32%	3,359 $283,000
Q1 2024 May 10, 2024	SELL	$68.64 - $89.2 $45,439 - $59,050	-662 Reduced 50.96%	637 $46,000
Q4 2023 Feb 12, 2024	SELL	$49.57 - $72.63 $12,095 - $17,721	-244 Reduced 15.81%	1,299 $92,000
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $11,242 - $13,879	191 Added 14.13%	1,543 $92,000
Q2 2023 Aug 10, 2023	BUY	$69.53 - $79.33 $903 - $1,031	13 Added 0.97%	1,352 $97,000
Q1 2023 May 12, 2023	SELL	$65.67 - $77.08 $1,970 - $2,312	-30 Reduced 2.19%	1,339 $98,000
Q4 2022 Feb 10, 2023	SELL	$61.72 - $96.74 $5,061 - $7,932	-82 Reduced 5.65%	1,369 $91,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $0 - $3,226	30 Added 2.11%	1,451 $125,000
Q2 2022 Aug 10, 2022	BUY	$74.52 - $117.06 $5,961 - $9,364	80 Added 5.97%	1,421 $127,000
Q1 2022 May 04, 2022	BUY	$94.99 - $151.56 $7,409 - $11,821	78 Added 6.18%	1,341 $151,000
Q3 2021 Nov 05, 2021	SELL	$102.33 - $144.73 $7,879 - $11,144	-77 Reduced 5.75%	1,263 $175,000
Q2 2021 Aug 02, 2021	SELL	$113.03 - $155.64 $51,541 - $70,971	-456 Reduced 25.39%	1,340 $175,000
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $56,228 - $121,943	-565 Reduced 23.93%	1,796 $273,000
Q4 2020 Feb 10, 2021	SELL	$80.55 - $106.05 $86,269 - $113,579	-1,071 Reduced 31.21%	2,361 $236,000
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $18,449 - $26,104	-206 Reduced 5.66%	3,432 $332,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $5,257 - $9,521	77 Added 2.16%	3,638 $407,000
Q1 2020 May 18, 2020	BUY	$63.37 - $107.88 $225,660 - $384,160	3,561 New	3,561 $257,000

Others Institutions Holding LGND

# of Institutions

343

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ligand Pharmaceuticals Inc Transaction History